Global aging and prevalence of neurodegenerative disorders are world-wide problems, however, there is no fundamental remedy yet.
Neuramedy aims to develop and provide breakthrough solutions for the cure of neurodegenerative diseases.
Our therapeutic focuses are Parkinson's disease (PD) and Alzheimer's disease (AD), two of the most common neurodegenerative diseases.
We are currently developing therapeutic antibodies and chemical drugs by taking advantage of (or utilizing) patent-protected state of the art (or cutting-edge) efficacy monitoring system.
